• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Playing catch-up with J&J, Sanofi taps Blackstone for $300M to fund pivotal trial of...

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Mar 15, 2022 at 11:22: AM
via Sanofi has turned to Blackstone Life Sciences for help developing a subcutaneous formulation of multiple myeloma drug Sarclisa. Blackstone is putting up $300 million to fund development of the formulation in return for a chance to receive royalties on future subcutaneous sales.

article source
 




Similar threads

cafead
Playing catch-up, Boehringer taps RetinAI for AI boost to eye disease R&D
Replies
0
Views
198
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Pfizer, playing catch-up with Novartis, bags FDA approval for drug combo in lung cancer
Replies
0
Views
237
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Bluebird, playing catch-up, gets decision date for sickle cell gene therapy
Replies
0
Views
363
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Playing catch-up to Big Pharma, Moderna posts come-from-behind RSV data
Replies
0
Views
134
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Playing in the Hot Obesity Market, Carmot Braves Chilly IPO Waters
Replies
0
Views
145
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote